GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
1d
I made four predictions about the stock market in 2024. The Fed indeed cut rates in Q4, but stocks didn't jump as much as I ...
BUCKSCO.Today on MSN2d
BioNTech Agrees to Pay $467M to Penn as Part of COVID-19 Vaccine Royalties SettlementUniversity of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine ...
The BioNTech SE ADR BNTX inched 0.42% higher to $115.79 Friday, on what proved to be an all-around great trading session for ...
GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...
The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...
A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.
The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair ...
The theory is solid, but creating such a bespoke vaccine quickly enough to be of use is a different matter. “Not many years ...
Geode Capital Management LLC trimmed its stake in BioNTech SE (NASDAQ:BNTX – Free Report) by 0.8% during the 3rd quarter, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback